A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation

Status Completed

Clinical Trial Summary

At a national level of 15%, the reoperation rate following augmentation mammaplasty is too high. We are conducting a survey to examine the pre-operative methods by which plastic surgeons determine implant volume, size, shape and location; and to determine if the Mentor "BodyLogic"TM System can successfully improve outcomes. We will evaluate how measurements taken using "BodyLogic"TM influence choice of implant and whether there are any re-operations, particularly for size change. We hypothesize that using this system will help surgeons choose appropriate implants that will decrease the rate of reoperations, especially for size change.

Clinical Trial Description

We are planning to survey 10 high volume plastic surgeons that perform at least 10 breast augmentations a month and to collect data on at least 300 patients. The enrollment period will be 3 months.

As part of this study, we are having the following steps performed:

1. Complete a 'general preference questionnaire', designed to document current preoperative planning and assessment methods for breast augmentation.

2. For each study patient, a pre-operative "BodyLogic"TM worksheet will be completed. Then, using the provided Implant Selection Booklet, the actual implant will be selected. The surgeon will maintain a key of the patients, and will identify them to the investigators only by subject number, and return these forms in provided stamped, self-addressed envelopes.

3. The patient returns at 1-3 months and 8-12 months for completion of the respective "Body-Logic" post-operative worksheets for each visit and the surgeon will send us the data in the provided envelopes periodically.

4. If during the course of the data collection, the surgeon has to re-operate on any patient, he/she will fill the "re-operative form" and send it to us.

5. Finally, the surgeon will complete a post-study evaluation questionnaire to help us understand how the "BodyLogic"TM System worked for him/her and how it could be improved. ;

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00684749
Study type	Observational
Source	University of Minnesota - Clinical and Translational Science Institute
Contact
Status	Completed
Phase	N/A
Start date	May 2008
Completion date	December 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03757793` - Near-infrared Spectroscopy for Monitoring Tissue Oxygenation in Breast Reconstruction
Completed	`NCT05491473` - Negative Pressure in PAP Donor Sites
Not yet recruiting	`NCT06013514` - Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
Completed	`NCT02169011` - Secondary Breast Reconstruction With a Flap of Skin From the Back	N/A
Completed	`NCT01216319` - Evaluation of the Cook Biodesign Plastic Surgery Matrix	N/A
Completed	`NCT01176786` - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery	N/A
Not yet recruiting	`NCT00973544` - Do Closed Suction Drains Affect the Complications Rate of Breast Reconstruction With Silicone Prosthesis?	N/A
Active, not recruiting	`NCT00748722` - Pre-Operative Imaging of Abdominal Wall Perforators Using CT Angiography	N/A
Completed	`NCT00753922` - Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses	Phase 3
Completed	`NCT05897463` - Nipple Neurotization
Recruiting	`NCT05377723` - Abdominal Scar Improvement in Microsurgical Breast Reconstruction	N/A
Completed	`NCT04350411` - Comparison of PEAK PlasmaBlade™ to Conventional Diathermy in Abdominal Based Free Flap Breast Reconstruction	N/A
Completed	`NCT06321549` - New Era of DIEP With Minimally Invasive Mastectomy
Withdrawn	`NCT03135392` - Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer	N/A
Completed	`NCT01256502` - The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery	N/A
Active, not recruiting	`NCT04715802` - Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
Active, not recruiting	`NCT04491591` - Implementing BREASTChoice Into Practice	N/A
Recruiting	`NCT04661501` - BREAST ADM Trial for Alloplastic Breast Reconstruction	N/A
Suspended	`NCT03625765` - Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye	N/A
Withdrawn	`NCT00778947` - Single Centre Study to Compare Harmonic Scalpel to Conventional Diathermy in Free Tissue Transfer Breast Reconstruction	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation Mammaplasty

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms